NIH Treatment Guidelines Being Developed
A panel of U.S. physicians, statisticians, and other experts has developed treatment guidelines for coronavirus disease 2019 (COVID-19).
One of the experts is PittPharmacy Alumna Safia Kuriakose, PharmD (2010), the Assistant Executive Secretary of the Panel.
Six clinical pharmacists, including five ACCP members, were selected to participate on the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel, based on their expertise in pharmacology, guidelines development, and experience in caring for patients with COVID-19.
These guidelines, intended for healthcare providers, are based on published and preliminary data and the clinical expertise of the panelists, many of whom are frontline clinicians caring for patients during the rapidly evolving pandemic
Read More: Guidelines
